Satoh Y, Kasama K, Usuki K, Naruse N, Ida N
Gan To Kagaku Ryoho. 1984 Feb;11(2):301-6.
Pharmacokinetic behaviors of human fibroblast interferon (HuIFN-beta) administered intravenously to rats were examined. After intravenous injection, plasma interferon level decreased in a biexponential fashion having the half-times of 15 min and 120 min respectively. Distribution levels of HuIFN-beta in the tissues at 30 min, though the actual concentrations were less than that of plasma, were observed according to the following order; kidney greater than adrenal greater than lung greater than spleen greater than liver greater than testis. Small amounts of HuIFN-beta were also detected in the thoracic lymph and bile but no HuIFN-beta was found in urine. The in vitro study indicated that the stability of HuIFN-beta was different in each tissue homogenates and body fluids. From the results obtained, we concluded that HuIFN-beta exhibited a low distributional character to the tissues when administered intravenously. It was also suggested that the kidney and the liver were the main catabolic sites of HuIFN-beta.
研究了静脉注射给大鼠的人成纤维细胞干扰素(HuIFN-β)的药代动力学行为。静脉注射后,血浆干扰素水平呈双指数下降,半衰期分别为15分钟和120分钟。30分钟时,HuIFN-β在组织中的分布水平虽实际浓度低于血浆,但按以下顺序观察到:肾脏>肾上腺>肺>脾脏>肝脏>睾丸。在胸导管淋巴液和胆汁中也检测到少量HuIFN-β,但尿液中未发现HuIFN-β。体外研究表明,HuIFN-β在各组织匀浆和体液中的稳定性不同。根据所得结果,我们得出结论,静脉给药时HuIFN-β在组织中的分布特征较低。还表明肾脏和肝脏是HuIFN-β的主要分解代谢部位。